LAST year’s KanaVape court case has prompted the European Union to re-think its stance in relation to two further cannabis-related matters.
A 12-page ‘non-paper’ released by the EU this week covers its position on cannabis in its different forms and components.
The non-paper – an EU term for an unofficial document put forward to test the reaction of other parties to possible procedural or policy changes – was presented to the Horizontal Working Party on Drug in June.
The subsequent report covering everything from the current recreational and medical use of cannabis to its agricultural, cosmetic and food uses as well as health and nutritional claims, highlights the impact recent judgements could have on EU policy.
These include the United Nations Commission on Narcotic Drugs’ decision last December to remove cannabis from the most restrictive drug classification and acknowledge its medical benefits.
It also includes last November’s ruling by the European Union’s Court of Justice (ECJ) that CBD is ‘not a narcotic.”
This ruling was made in relation to the 2014 French prosecution of two businessmen importing Czech CBD extracts from whole hemp plants.